The anticancer effects of desferrioxamine on human breast adenocarcinoma and hepatocellular carcinoma cells
 
Yazarlar (6)
Osman Saliş
Ondokuz Mayis Üniversitesi, Türkiye
Abdülkerim Bedir
Ondokuz Mayis Üniversitesi, Türkiye
Veli Kılınç
Trabzon Public Health Laboratory, Türkiye
Hasan Alaçam
Ondokuz Mayis Üniversitesi, Türkiye
Doç. Dr. Sedat GÜLTEN Kastamonu Üniversitesi, Türkiye
Ali Okuyucu
Ondokuz Mayis Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Cancer Biomarkers
Dergi ISSN 1574-0153 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2014
Kabul Tarihi Yayınlanma Tarihi 10-10-2014
Cilt / Sayı / Sayfa 14 / 6 / 419–426 DOI 10.3233/CBM-140422
Makale Linki http://dx.doi.org/10.3233/cbm-140422
UAK Araştırma Alanları
Tıbbi Biyokimya
Özet
N-myc downstream-regulated gene 1 (NDRG1) is defined as metastasis suppressor and can be downregulated in many types of cancers, and reported to be an indication of tumor progression in hepatocellular carcinomas. Several in-vivo and in-vitro studies have demonstrated that iron chelators such as Desferrioxamine (DFO) and 1–10 Phenanthroline (PHEN) are effective antitumor agents. It is suggested that these chelators deliver their antitumor activity by acting on the NDRG1 gene expression. It remains unclear why NDRG1 gene expression affects the tumors differently, or becomes affected differently. We consider that this different effect might be caused by variants. Based on this information, we developed specific primers and probes for NDRG1 mRNA variants using bioinformatics analysis, and investigated how DFO and PHEN affected the dynamics of NDRG1 variant on the cell lines of Human Breast …
Anahtar Kelimeler
Desferrioxamine | Human breast adenocarcinoma and hepatocellular carcinoma | N-myc downstream-regulated gene 1
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 25
Scopus 27
Google Scholar 38
The anticancer effects of desferrioxamine on human breast adenocarcinoma and hepatocellular carcinoma cells

Paylaş